Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito
FrancoAngeli Journals

Newsletter "Clinica dell'Alcolismo"

N. 74 (2026)

Titolazione individualizzata del sodio oxibato in un disturbo da uso di alcol con uso improprio di benzodiazepine: un case report sulla personalizzazione della cura e la gestione sequenziale degli obiettivi terapeutici

DOI
https://doi.org/10.3280/mis74-2026oa23188
Inviata
2 luglio 2026
Pubblicato
27-07-2026

Riferimenti bibliografici

  1. World Health Organization (2024). Global status report on alcohol and health 2024. Geneva: WHO.
  2. Rehm J., Anderson P., Manthey J. et al. (2021). Alcohol use and burden. Alcohol Alcohol., 56(4): 422-427.
  3. Kwako L.E., Momenan R., Litten R.Z. et al. (2016). Addictions neurobiology. Biol Psychiatry, 80(3): 179-189.
  4. Addolorato G., Leggio L., Ferrulli A. et al. (2006). Baclofen/GHB and alcohol dependence. Lancet, 367: 1503-1510.
  5. Addolorato G., Caputo F., Capristo E. et al. (2009). GHB in alcohol dependence. Alcohol., 43(2): 133-139.
  6. Caputo F., Vignoli T., Leggio L., Addolorato G., & Bernardi M. (2014). Pharmacological management of alcohol dependence. Expert Opin Pharmacother., 15(2): 245-257.
  7. Mann K., & Soyka M. (2017). Pharmacotherapy of alcohol dependence. CNS Drugs., 31(4): 255-272.
  8. Witkiewitz K., Litten R.Z., & Leggio L. (2019). Advances in AUD treatment science. Sci Adv., 5(9), eaax4043.
  9. Kwako L.E., Schwandt M.L., Ramchandani V.A. et al. (2019). Neurofunctional domains in AUD. Biol Psychiatry., 86(11): 866-879.
  10. Caputo F., Addolorato G., Capristo E. et al. (2010). Sodium oxybate in AUD. Expert Opin Pharmacother., 16(19): 2114-2117.
  11. European Association for the Study of the Liver (EASL) (2018). Alcohol-related liver disease guidelines. J Hepatol., 69(1): 154-181.
  12. American Psychiatric Association (2018). Practice guideline for AUD. Am J Psychiatry., 175(1): 86-90.
  13. Volkow N.D., Koob G.F., & McLellan A.T. (2016). Brain disease model of addiction. N Engl J Med., 374(4): 363-371.
  14. McLellan A.T., Lewis D.C., O’Brien C.P., & Kleber H.D. (2000). Addiction as chronic illness. JAMA, 284(13): 1689-1695.
  15. National Institute for Health and Care Excellence (NICE) (2011). CG115 Alcohol-use disorders. London: NICE.
  16. Saitz R. (2005). Unhealthy alcohol use. N Engl J Med., 352(6): 596-607.
  17. Caputo F., Domenicali M., et al. (2016). Sodium oxybate effi cacy. Alcohol Alcohol., 51(3): 312-318.
  18. Skala K., Caputo F., Mirijello A., et al. (2014). Sodium oxybate in AUD. Expert Opin Pharmacother., 15(2): 245-257.